Contact Lens Spectrum


June 2019

Document #283

(p. 12) Prescribing for Presbyopia – Multifocal Lens Use for Presbyopia
By Matthew Lampa, OD

  1. Young G. Why one million contact lens wearers dropped out. Contact Lens Anterior Eye. 2004 Jun;27:83-85.
  2. Richdale K, Sinnott LT, Skadahl E, Nichols JJ. Frequency of and factors associated with contact lens dissatisfaction and discontinuation. Cornea. 2007 Feb;26:168-174.
  3. Dumbleton K, Woods, CA, Jones LW, Fonn D. The impact of contemporary contact lenses on contact lens discontinuation. Eye Contact Lens. 2013 Jan;39:93-99.
  4. Morgan P, Woods C, Tranoudis IG, et al. International Contact Lens Prescribing in 2018. Contact Lens Spectrum. 2019 Jan;34:26-32.
  5. Nichols J, Fisher D. Contact Lenses 2018. Contact Lens Spectrum. 2019 Jan;34:18-23, 51.

(p. 14) Dry Eye Dx and Tx – The Magic Happening That We Can’t See
By Katherine M. Mastrota, MS, OD

  1. Ricardo JR, Cristovam PC, Filho PA, et al. Transplantation of conjunctival epithelial cells cultivated ex vivo in patients with total limbal stem cell deficiency. Cornea. 2013 Mar;32:221-228.
  2. Dhamodaran K, Subramani M, Ponnalagu M, Shetty R, Das D. Ocular stem cells: a status update! Stem Cell Res Ther. 2014;5(2):56.
  3. Bernard BA. [Hair cycle dynamics: the case of the human hair follicle]. J Soc Biol. 2003;197(1):57-61.
  4. Aumond S, Bitton E. The eyelash follicle features and anomalies: A review. J Optom. 2018 Oct-Dec;11(4):211-222.

(p. 42) Contact Lens Practice Pearls – Partial Correction Is Not a Shoddy Job
By David L. Kading, OD

  1. Charm J, Cho P. High myopia-partial reduction ortho-k: a 2-year randomized study. Optom Vis Sci. 2013 Jun;90:530-539.

(p. 45) Pediatric and Teen CL Care – Lenses for Congenital Ocular Conditions
By Melanie Frogozo, OD

  1. Troilo D. Neonatal eye growth and emmetropisation--a literature review. Eye (Lond). 1992;6(Pt 2):154-160.
  2. Vincent SJ. The use of contact lenses in low vision rehabilitation: optical and therapeutic applications. Clin Exp Optom. 2017 Sep;100:513-521.
  3. Dias L, Manny RE, Weissberg E, Fern KD. Myopia, contact lens use and self-esteem. Ophthalmic Physiol Opt. 2013 Sep;33:573-580.
  4. Saw SM, Gazzard G, Shih-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic Physiol Opt. 2005 Sep;25:381-391.
  5. Allen ED, Davies PD. Role of contact lenses in the management of congenital nystagmus. Br J Ophthalmol. 1983 Dec;67:834-836.
  6. Taibbi G, Wang ZI, Dell’Osso LF. Infantile nystagmus syndrome: Broadening the high-foveation-quality field with contact lenses. Clin Ophthalmol. 2008 Sep;2:585-589.

(p. 46) Prescribing for Astigmatism – When Regular Astigmatism Goes Awry
By Manveen Bedi, OD; Jocelyn Ou, OD; & Timothy B. Edrington, OD, MS

  1. Gordon-Shaag A, Millodot M, Shneor E, Liu Y. The genetic and environmental factors for keratoconus. Biomed Research International. 2015;2015:795738.
  2. Sharma N, Rao K, Maharana PK, Vajpayee RB. Ocular allergy and keratoconus. Indian J Ophthalmol. 2013 Aug;61:407-409.
  3. Gupta PK, Stinnett SS, Carlson AN. Prevalence of sleep apnea in patients with keratoconus. Cornea. 2012 Jun;31:595-599.
  4. Zadnik K, Mannis MJ, Johnson CA, Rich D. Rapid contrast sensitivity assessment in keratoconus. Am J Optom Physiol Opt. 1987 Sep;64:693-697.
  5. Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Experimental Eye Research. 1998 Jan;66:97-103.
  6. Mohammadpour M, Masoumi A, Mirghorbani M, Shahraki K, Hashemi H. Updates on corneal collagen cross-linking: Indications, techniques and clinical outcomes. J Curr Ophthalmol. 2017 Sep 12;29:235-247.

(p. 48) Reader and Industry Forum – Limbal Stem Cell Deficiency in Stevens-Johnson Syndrome
By Kent Nguyen, OD, & Gloria B. Chiu, OD

  1. Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea. 2007 Feb;26:123-129.
  2. Antoon JW, Goldman JL, Lee B, Schwartz A. Incidence, outcomes, and resource use in children with Stevens-Johnson syndrome and toxic epidermal necrolysis. Pediatr Dermatol. 2018 Mar;35:182-187.
  3. Catt CJ, Hamilton GM, Fish J, Mireskandari K, Ali A. Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children. Am J Ophthalmol. 2016 Jun;166:68-75.
  4. Chantaphakul H, Sanon T, Klaewsongkram J. Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis. Exp Ther Med. 2015 Aug;10:519-524.
  5. Ahmad S, Osei-Bempong C, Dana R, Jurkunas U. The culture and transplantation of human limbal stem cells. J Cell Physiol. 2010 Oct;225:15-19.
  6. Puangsricharern V, Tseng SC. Cytologic evidence of corneal diseases with limbal stem cell deficiency. Ophthalmology. 1995 Oct;102:1476-1485.
  7. Chan CC, Holland EJ. Severe limbal stem cell deficiency from contact lens wear: patient clinical features. Am J Ophthalmol. 2013 Mar;155:544-549.e2.
  8. Kim BY, Riaz KM, Bakhtiari P, et al. Medically reversible limbal stem cell disease: clinical features and management strategies. Ophthalmology. 2014 Oct;121:2053-2058.
  9. Sotozono C, Ueta M, Koizumi N, et al. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology. 2009 Apr;116:685-690.
  10. Heur M, Bach D, Theophanous C, Chiu GB. Prosthetic replacement of the ocular surface ecosystem scleral lens therapy for patients with ocular symptoms of chronic Stevens-Johnson syndrome. Am J Ophthalmol. 2014 Jul;158:49-54.